Globus Medical Net Income 2010-2024 | GMED

Globus Medical annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Globus Medical net income for the quarter ending September 30, 2024 was $0.052B, a 5093.99% increase year-over-year.
  • Globus Medical net income for the twelve months ending September 30, 2024 was $0.092B, a 42.04% decline year-over-year.
  • Globus Medical annual net income for 2023 was $0.123B, a 35.39% decline from 2022.
  • Globus Medical annual net income for 2022 was $0.19B, a 27.47% increase from 2021.
  • Globus Medical annual net income for 2021 was $0.149B, a 45.86% increase from 2020.
Globus Medical Annual Net Income
(Millions of US $)
2023 $123
2022 $190
2021 $149
2020 $102
2019 $155
2018 $156
2017 $107
2016 $104
2015 $113
2014 $92
2013 $69
2012 $74
2011 $61
2010 $54
2009 $40
Globus Medical Quarterly Net Income
(Millions of US $)
2024-09-30 $52
2024-06-30 $32
2024-03-31 $-7
2023-12-31 $15
2023-09-30 $1
2023-06-30 $58
2023-03-31 $49
2022-12-31 $50
2022-09-30 $47
2022-06-30 $55
2022-03-31 $38
2021-12-31 $15
2021-09-30 $47
2021-06-30 $42
2021-03-31 $45
2020-12-31 $53
2020-09-30 $44
2020-06-30 $-21
2020-03-31 $26
2019-12-31 $46
2019-09-30 $38
2019-06-30 $38
2019-03-31 $33
2018-12-31 $37
2018-09-30 $35
2018-06-30 $45
2018-03-31 $40
2017-12-31 $24
2017-09-30 $26
2017-06-30 $29
2017-03-31 $29
2016-12-31 $24
2016-09-30 $26
2016-06-30 $26
2016-03-31 $28
2015-12-31 $38
2015-09-30 $26
2015-06-30 $24
2015-03-31 $25
2014-12-31 $28
2014-09-30 $23
2014-06-30 $21
2014-03-31 $21
2013-12-31 $21
2013-09-30 $20
2013-06-30 $7
2013-03-31 $20
2012-12-31 $21
2012-09-30 $16
2012-06-30 $19
2012-03-31 $18
2011-12-31 $14
2011-09-30 $17
2011-06-30 $13
2011-03-31 $12
2010-12-31
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $11.262B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $200.813B 24.50
Intuitive Surgical (ISRG) United States $194.018B 101.44
Edwards Lifesciences (EW) United States $43.628B 27.70
Alcon (ALC) Switzerland $42.291B 28.30
IQVIA Holdings (IQV) United States $36.367B 20.04
IDEXX Laboratories (IDXX) United States $35.798B 42.16
DexCom (DXCM) United States $30.830B 46.43
Waters (WAT) United States $22.743B 33.63
STERIS (STE) Ireland $21.361B 24.59
SONOVA HOLDING (SONVY) Switzerland $19.498B 0.00
Hologic (HOLX) United States $17.041B 18.40
Fresenius Medical Care AG KGaA (FMS) Germany $13.902B 14.27
Sysmex ADR (SSMXY) Japan $12.298B 38.57
Penumbra (PEN) United States $9.682B 94.83
Masimo (MASI) United States $9.374B 45.36
Teleflex (TFX) United States $8.514B 13.58
Glaukos (GKOS) United States $7.737B 0.00
PROCEPT BioRobotics (PRCT) United States $4.687B 0.00
Integer Holdings (ITGR) United States $4.672B 26.48
Veracyte (VCYT) United States $3.441B 103.26
Inari Medical (NARI) United States $3.299B 0.00
LivaNova (LIVN) United Kingdom $2.830B 16.33
Nihon Kohden (NHNKY) Japan $2.541B 19.30
Tandem Diabetes Care (TNDM) United States $2.253B 0.00
TransMedics (TMDX) United States $2.205B 69.90
Elekta AB (EKTAY) Sweden $2.177B 19.57
Integra LifeSciences Holdings (IART) United States $1.870B 9.77
RxSight (RXST) United States $1.447B 0.00
Alphatec Holdings (ATEC) United States $1.376B 0.00
Artivion (AORT) United States $1.237B 81.94
OPKO Health (OPK) United States $1.099B 0.00
Pulse Biosciences (PLSE) United States $1.054B 0.00
Paragon 28 (FNA) United States $0.856B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.847B 14.41
ORTHOFIX MEDICAL INC (OFIX) United States $0.691B 0.00
Mesa Laboratories (MLAB) United States $0.691B 16.28
IRadimed (IRMD) United States $0.690B 37.28
AxoGen (AXGN) United States $0.634B 0.00
Semler Scientific (SMLR) United States $0.595B 35.04
SiBone (SIBN) United States $0.571B 0.00
Pacific Biosciences Of California (PACB) United States $0.560B 0.00
OrthoPediatrics (KIDS) United States $0.531B 0.00
Treace Medical Concepts (TMCI) United States $0.475B 0.00
ClearPoint Neuro (CLPT) United States $0.452B 0.00
Tactile Systems Technology (TCMD) United States $0.435B 23.55
Delcath Systems (DCTH) United States $0.377B 0.00
AngioDynamics (ANGO) United States $0.373B 0.00
NeuroPace (NPCE) United States $0.326B 0.00
CVRx (CVRX) United States $0.325B 0.00
Inogen (INGN) United States $0.221B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.202B 0.00
Accuray (ARAY) United States $0.193B 0.00
Sight Sciences (SGHT) United States $0.189B 0.00
Nevro (NVRO) United States $0.158B 0.00
Atossa Genetics (ATOS) United States $0.145B 0.00
Sensus Healthcare (SRTS) United States $0.139B 14.90
Spectral Diagnostics (EDTXF) Canada $0.104B 0.00
LENSAR (LNSR) United States $0.090B 0.00
Monogram Orthopaedics (MGRM) United States $0.088B 0.00
Vicarious Surgical (RBOT) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.082B 0.00
InspireMD (NSPR) Israel $0.081B 0.00
908 Devices (MASS) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
WORK Medical Technology Group (WOK) China $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.050B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.044B 0.00
Envoy Medical (COCH) United States $0.042B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Accelerate Diagnostics (AXDX) United States $0.034B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Adagio Medical Holdings (ADGM) United States $0.031B 0.00
NexGel (NXGL) United States $0.030B 0.00
Biosig Technologies (BSGM) United States $0.030B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.013B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.010B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
T2 Biosystems (TTOO) United States $0.009B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00